Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Another California lawsuit on heartburn drug Zantac settled by GSK

Ruchika Sharma11 Oct 2023 4:30 PM IST

The FDA in 2020 pulled all brand name Zantac and generic versions of the drug off the market, triggering a wave of lawsuits.

Dr Reddys Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream

Cancer drug: Dr Reddy's arm faces antitrust complaint in US over Revlimid

Ruchika Sharma11 Oct 2023 3:30 PM IST

Telangana: Dr Reddy’s Laboratories, Inc., a wholly-owned step-down subsidiary of Dr Reddy’s Laboratories Limited, along with several other...

Indian Pharmacopoeia Commission becomes member of Pharmacopoeial Discussion Group

Ruchika Sharma11 Oct 2023 2:15 PM IST

Membership in the PDG would enhance the international recognition of the standards set by the IPC. This also has potential to improve the acceptance...

USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers Squibb

Bristol Myers Squibb, Paradigm collaborate to build new model for clinical trials

Ruchika Sharma11 Oct 2023 12:21 PM IST

Columbus: Paradigm has announced a collaboration with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche

Ruchika Sharma10 Oct 2023 2:30 PM IST

Basel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis Cosentyx IV formulation for rheumatic diseases bags USFDA okay

Ruchika Sharma10 Oct 2023 1:30 PM IST

The IV formulation of Cosentyx offers patients a monthly 30-minute, weight-based dosing option, requiring no pre-medication and no lab monitoring.

Expanded age indication for GSK’s AREXVY

GSK, Zhifei to co-promote shingles vaccine Shingrix in China

Ruchika Sharma10 Oct 2023 12:30 PM IST

Subject to the terms of the agreement, Zhifei will purchase agreed volumes of Shingrix with a value to GSK of £2.5 billion in total over the initial...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck Keytruda met primary endpoint of disease free survival in certain patients with Muscle-Invasive Urothelial Carcinoma after surgery

Ruchika Sharma10 Oct 2023 11:30 AM IST

KEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...

Novo Nordisk Projects Oral Weight-Loss Pills to Take One-Third of GLP-1 Market by 2030

Novo Nordisk to stop once-weekly injectable semaglutide kidney outcomes trial

Ruchika Sharma10 Oct 2023 11:00 AM IST

"Based on the decision to stop the trial at interim, the process of closing the trial will be initiated. To protect the integrity of the trial, Novo...

Bristol-Myers Squibb to acquire Mirati

Ruchika Sharma9 Oct 2023 3:30 PM IST

Princeton: Bristol Myers Squibb and Mirati Therapeutics, Inc. have announced that they have entered into a definitive merger agreement under...

India among world top 5 healthcare manufacturers, but at much lesser cost: Dr Jitendra Singh

Ruchika Sharma9 Oct 2023 3:30 PM IST

"India is set to become the global hub of medical technology and devices with the market size estimated to grow up to US$ 50 billion by 2050 from the...

Safipur CHC Burns Medicines, Investigation Launched

UP: State-of-art Meditech Park being developed on 350 acres near Jewar Airport

Ruchika Sharma9 Oct 2023 1:30 PM IST

Lucknow: The Uttar Pradesh Government is working on a war footing to develop a pharmaceutical park at Lalitpur, a state-of-the-art Meditech Park near...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok